Lung Cancer Diagnosis and Treatment - The Impact of PET Imaging and Targeted Therapies

PET Imaging & Targeted Therapies in Cancer: A Masterclass Series

SESSION FOUR: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies

This session delves into the pivotal role of PET imaging in the diagnosis, staging, and treatment of lung cancer. Participants will explore how PET scans enhance early detection and provide critical insights into treatment efficacy, enabling clinicians to make more accurate decisions throughout the care continuum. Additionally, the session will examine the use of targeted therapies in lung cancer, highlighting how PET imaging can guide the tailoring of these therapies for optimal patient outcomes. Leading experts in the field will share their knowledge and real-world experience to illustrate the integration of PET imaging with cutting-edge targeted treatment strategies.

SESSION BREAKDOWN

Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:

Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care

Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies

Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies

Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies

Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies

EARN CPD POINTS

Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.

WHY REGISTER AND ATTEND THIS TRAINING SERIES?

This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.

SESSION 3: PET Imaging and Targeted Therapies in Hematological Malignancies

This session focuses on the pivotal role of PET imaging in the diagnosis, staging, and treatment monitoring of hematological malignancies, including lymphoma and leukemia. Participants will gain insights into the integration of PET scans into clinical workflows, enhancing the accuracy of disease detection and therapeutic response evaluation. Additionally, the session explores advancements in targeted treatments for hematological cancers and how PET imaging aids in optimizing these therapies. Facilitated by leading experts, this interactive session is designed to empower participants with cutting-edge knowledge and practical strategies to enhance outcomes in hematological.

ORGANIZED BY

PROUDLY SPONSORED BY

This virtual training will premier on Thursday the 12th of December 2024 at 4:00 PM.  

Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists

Moderator: Dr. Amankwaa Frempong

Date: Thursday 12th December 2024

Time: 16:00 GMT (4:00 pm local time)

AGENDA

Thursday 12th December 2024 (VIRTUAL EVENT)